Entity: all
News about BIOD
ShareAnalyse the news about BIOD from multiple sources, get visualizations or extract the entire dataset.
Related dashboards:
- BIOD (object)
This biotech stock is a buy thanks to its cancer treatment pipeline, Citi says
Leerink upgrades this beaten-down biotech stock, says investors should buy the dip
This little-known biotech stock is a buy that's primed to double in price, Goldman says
This biotech stock is an 'oncology powerhouse' with 40% upside, says Truist Securities
These innovative biotech stocks have a good chance of breaking out in 2025
JPMorgan's top biotech stock picks for 2025 as sector looks for a comeback year
These 9 biotech stocks have doubled this year and are set to double again, analysts say
Time to 'cut off' US outbound investment in China biotech firms like BGI Group and Wuxi AppTec: House panel
'A trove of rebound opportunities': Strategists turn bullish on biotech and more, picking top stocks
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
This biotech stock targeting genetically driven diseases could nearly double, predicts JPMorgan
Dataset
Extract all news on this scope:
Analysis
See the trend on this scope:
Evolution through time
Sources analysis:
Distribution of sources in the news
Sections analysis:
Distribution of sections in the news
Current sentiment polarity: slightly positive with a score of 0.65
| positive | 70% | |
| neutral | 30% |
Sentiment polarity through time
